Literature DB >> 8379153

Fibrinogen and atherosclerosis.

E B Smith1.   

Abstract

Fibrin appears to be a multi-potential component of atherogenesis, intervening at virtually all stages of lesion development. Fibrin and microthrombus deposition on normal intima is associated with endothelial disruption and intimal oedema, and oedema is a primary characteristic of early proliferative lesions. Fibrin strands on or in the intima encourage smooth muscle cell (SMC) migration and proliferation, and contribute to the growth of plaques. Fibrin also provides a continuing source of fibrin degradation products (FDP), and these have mitogenic activity which will sustain SMC proliferation in growing plaques, and act as chemoattractants for blood leucocytes. Accumulation of the lipid core in fibrous plaques may also be influenced by fibrin which appears to bind the lipoprotein Lp(a) with high affinity, thereby immobilizing its lipid moiety within the lesion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8379153

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  4 in total

1.  Nanoparticle-induced vascular blockade in human prostate cancer.

Authors:  Lilach Agemy; Kazuki N Sugahara; Venkata Ramana Kotamraju; Kunal Gujraty; Olivier M Girard; Yuko Kono; Robert F Mattrey; Ji-Ho Park; Michael J Sailor; Ana I Jimenez; Carlos Cativiela; David Zanuy; Francisco J Sayago; Carlos Aleman; Ruth Nussinov; Erkki Ruoslahti
Journal:  Blood       Date:  2010-06-29       Impact factor: 22.113

Review 2.  Bezafibrate. An update of its pharmacology and use in the management of dyslipidaemia.

Authors:  K L Goa; L B Barradell; G L Plosker
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

3.  Targeting atherosclerosis by using modular, multifunctional micelles.

Authors:  David Peters; Mark Kastantin; Venkata Ramana Kotamraju; Priya P Karmali; Kunal Gujraty; Matthew Tirrell; Erkki Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-01       Impact factor: 11.205

4.  Lp(a) lipoprotein levels as a predictor of risk for thrombogenic events in patients with Behçet's disease.

Authors:  A Orem; O Değer; O Memiş; S Bahadir; E Ovali; G Cimşit
Journal:  Ann Rheum Dis       Date:  1995-09       Impact factor: 19.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.